Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
about
Enzyme replacement and substrate reduction therapy for Gaucher diseaseGaucher disease: the role of the specialist on metabolic bone diseasesUnderstanding the natural history of Gaucher diseaseVelaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials.Achievement of therapeutic goals with low-dose imiglucerase in Gaucher disease: a single-center experience.Unexpected macrophage-independent dyserythropoiesis in Gaucher disease.Treatment of profound thrombocytopenia in a patient with Gaucher disease type 1: Is there a role for substrate reduction therapy.The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease.Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3)Improvement in Bone Mineral Density and Architecture in a Patient with Gaucher Disease Using Teriparatide.Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned.Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry.Assessment of Bone Health in Patients With Type 1 Gaucher Disease Using Impact Microindentation.Skeletal involvement in Gaucher disease: An observational multicenter study of prognostic factors in the Argentine Gaucher disease patients.The history and accomplishments of the ICGG Gaucher registry.Gaucher disease
P2860
Q24187121-AF3F1FE9-B879-4E51-8F91-08845DCBFB95Q26775745-9DC0691C-B59B-4E82-969B-A3C97ECBF864Q26865974-EC5E3C34-D574-46F8-A46D-1774DBA61583Q30914683-FC06547C-D050-46CF-88BF-F9C87D4A6D71Q33411773-8A8B7460-6249-42B3-989B-BABA12C58F81Q33434241-56363211-78C6-45C7-9D6B-DB2703E7A239Q33443605-41818BF2-7BB6-4640-AE0F-4F074A578EEAQ35611123-6CF8D6EB-4601-468D-9837-91DD817410CFQ35754621-AA9419EA-0D62-4177-8790-1EA855EFFB4AQ35801017-744CA99D-C02D-4B53-9550-2F5F11F7FF1DQ38219852-8375F9A4-2C7E-4348-B7E8-8FE1ECD522ABQ38262722-9D7279A8-F73F-4B61-8C95-9DA519B47714Q38533848-384DBC10-4BB0-4706-8ED1-9C8D54157ECFQ38927495-FD4513E5-800F-4835-9454-3C59C2C2271EQ40649689-0374B11A-27F9-429A-BEC8-D04B84F554ECQ41652308-DF51D976-3E5E-4433-B339-494BA9350090Q56338451-2985C87B-4B67-4204-ABC5-A62A749EB724
P2860
Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Risk factors for fractures and ...... Group (ICGG) Gaucher Registry.
@en
Risk factors for fractures and ...... al Collaborative Gaucher Group
@nl
type
label
Risk factors for fractures and ...... Group (ICGG) Gaucher Registry.
@en
Risk factors for fractures and ...... al Collaborative Gaucher Group
@nl
prefLabel
Risk factors for fractures and ...... Group (ICGG) Gaucher Registry.
@en
Risk factors for fractures and ...... al Collaborative Gaucher Group
@nl
P2093
P2860
P356
P1476
Risk factors for fractures and ...... Group (ICGG) Gaucher Registry.
@en
P2093
Aneal Khan
John S Taylor
Neal J Weinreb
Pramod K Mistry
Thomas Hangartner
P2860
P304
P356
10.1002/JBMR.1680
P577
2012-08-01T00:00:00Z